Taltirelin
Alternative Names: Ceredist; TA-0910; Taltirelin hydrateLatest Information Update: 24 Oct 2021
At a glance
- Originator Tanabe Seiyaku
- Developer Mitsubishi Tanabe Pharma Corporation
- Class Antidementias; Neuropeptides; Neuroprotectants; Oligopeptides; Pituitary hormone releasing hormones
- Mechanism of Action Thyrotropin-releasing hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Neurological disorders; Spinocerebellar degeneration
Most Recent Events
- 26 Oct 2009 Oral disintegrating tablet formulation launched for Spinocerebellar degeneration in Japan (PO)
- 30 Jun 2009 Registered for Spinocerebellar degeneration in Japan (PO)
- 01 Oct 2007 Mitsubishi Pharma Corporation has merged with Tanabe Seiyaku to form Mitsubishi Tanabe Pharma Corporation